
Adipogen/SANT-2/AG-CR1-3514-M001/1 mg
商品编号:
AG-CR1-3514-M001
品牌:
Adipogen Inc
市场价:
¥700.00
美元价:
420.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | N-[3-(1H-Benzimidazol-2-yl)-4-chlorophenyl]-3,4,5-triethoxybenzamide |
ProductType | Chemical |
Properties | |
Formula | C26H26ClN3O4 |
MW | 480.0 |
CAS | 329196-48-7 |
PurityChemicals | ≥95%(NMR) |
Appearance | Whitetooff-whitesolid. |
Solubility | SolubleinDMSO,ethanolorchloroform. |
Identity | Determinedby1H-NMR. |
InChiKey | VQOJFGFKIVFMDH-UHFFFAOYSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | -20°C |
HandlingAdvice | Protectfromlight. |
Use/StABIlity | Stableforatleast2yearsafterreceiptwhenstoredat-20°C. Storesolutionsat-20°Cinthedark. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
- Sonichedgehog(Shh)signalingpathwaymodulator.
- Cellpermeablepotentsmoothened(Smo)antagoNIST.InhibitswtandoncogenicSmo.
- SAGactivity(Prod.Nr.AG-CR1-3506)inhibitor.
- Gli1reportergeneexpressioninhibitor.
- SuppressestheShh-dependenttranslocationofSmototheprimarycilium.
- Potentialtumorgrowthblocker.
ProductReferences
- SmallmoleculemodulationofSmoothenedactivity:J.K.Chen,etal.;PNAS99,14071(2002)
- TargetingtheHedgehogpathwayincancer:L.L.Rubin&F.J.deSauvage;Nat.Rev.Drug.Discov.5,1026(2006)(Review)
- Evidenceforallostericinteractionsofantagonistbindingtothesmoothenedreceptor:C.M.Rominger,etal.;J.Pharmacol.Exp.Ther.329,995(2009)
- HedgehogsignaltransductionbySmoothened:pharmacologicevidencefora2-stepactivationprocess:R.Rohatgi,etal.;PNAS106,3196(2009)
- SynthesisandBIOLOGicalevaluationofSANT-2andanaloguesasinhibitorsofthehedgehogsignalingpathway:A.Büttner,etal.;Bioorg.Med.Chem.17,4943(2009)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们